George L. Sing - 16 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
16 Nov 2021
Net transactions value
-$7,025,080
Form type
4
Filing time
18 Nov 2021, 15:09:19 UTC
Previous filing
30 Aug 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,300,000 -2,000 -4.7% $650.00 40,858 16 Nov 2021 Direct
transaction REGN Common Stock Sale $1,317,580 -2,000 -4.9% $658.79 38,858 16 Nov 2021 Direct
transaction REGN Common Stock Sale $1,320,000 -2,000 -5.1% $660.00 36,858 16 Nov 2021 Direct F1
transaction REGN Common Stock Sale $2,600,000 -4,000 -11% $650.00 32,858 18 Nov 2021 Direct
transaction REGN Common Stock Sale $487,500 -750 -43% $650.00 1,000 16 Nov 2021 by Trust for Son
holding REGN Common Stock 750 16 Nov 2021 by Spouse
holding REGN Common Stock 400 16 Nov 2021 by Spouse/Cust Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 16, 2021 at prices ranging from $660.00 to $660.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.